GKS Presents Research Poster at BARDA BioMaP-Consortium General Membership Meeting 2026

Global Key Solutions is presenting a research poster at the BioMaP-Consortium General Membership Meeting on February 25–26, 2026 in Arlington, VA. The event is organized by ATI in partnership with BARDA and ASPR, and focuses on strengthening domestic biopharmaceutical manufacturing capabilities.

The Poster

Our poster, "The Foreign Inspection Gap: Regulatory Data Intelligence for Global GMP Oversight," presents findings from our ongoing research on FDA foreign inspection trends from 2014–2024, along with an overview of the KeyPedia platform.

Key Findings

• 23 fewer inspections for every additional $1 billion of drug imports (2014–2019)
• China inspection intensity down 82% (101.8 → 18.3 per billion USD)
• Foreign facilities showed observation rates 1.3–1.8x higher than the U.S. baseline (49.3%)

These findings provide empirical support for the FDA's May 6, 2025 policy shift toward unannounced foreign facility inspections.

The Event

GKS is one of 14 organizations selected to present posters at the meeting, alongside KBI Biopharma, General Therapeutics, Arranta Bio, and others. The two-day agenda features keynotes from ASPR and BARDA leadership, panels on onshoring pharmaceutical manufacturing, and sessions on supply chain resilience.

Related Research

• Preprint: The Foreign Inspection Gap: FDA GMP Oversight of U.S. Drug Imports, 2014–2024 — Research Square, 2025
• Published: An Analysis of FDA Warning Letter Citations from 2019–2023 — J. Pharm. Innov. 19, 78 (2024)

For more information, questions, or to see KeyPedia in action, try KeyPedia Light or schedule a demo. You can also reach us at [email protected].